Medicinal preparations obtained by treating materials with wave energy or particle radiation (A 61 K 31/59 takes precedence; electric discharge tubes H 01 J) [2]
Medicinal preparations containing active ingredients not provided for in groups A 61 K 31/00 to A 61 K 41/00 [2,6]
45
/
05
•
Immunological preparations stimulating the recticulo-endothelial system, e.g. against cancer [3]
45
/
06
•
Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca [2]
45
/
08
•
Mixtures of an active ingredient and an auxiliary substance neither being chemically characterised, e.g. antihistaminicum and surface active substance [2]
47
/
00
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives [2]
47
/
02
•
Inorganic compounds [5]
47
/
04
•
•
Non-metals; Compounds thereof [5]
47
/
06
•
Organic compounds [5]
47
/
08
•
•
containing oxygen [5]
47
/
10
•
•
•
Alcohols; Phenols; Salts thereof [5]
47
/
12
•
•
•
Carboxylic acids; Salts or anhydrides thereof [5]
47
/
14
•
•
•
Esters of carboxylic acids [5]
47
/
16
•
•
containing nitrogen [5]
47
/
18
•
•
•
Amines; Quaternary ammonium compounds [5]
47
/
20
•
•
containing sulfur [5]
47
/
22
•
•
Heterocyclic compounds [5]
47
/
24
•
•
containing atoms other than carbon, hydrogen, halogen, oxygen, nitrogen or sulfur [5]
47
/
26
•
•
Carbohydrates [5]
47
/
28
•
•
Steroids [5]
47
/
30
•
Macromolecular compounds [5]
47
/
32
•
•
Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds [5]
47
/
34
•
•
Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds [5]
Preparations containing radioactive substances for use in therapy or testing in vivo [6]
Note
In this group, it is desirable to add the indexing codes of groups A 61 K 101:00 to A 61 K 123:00. The indexing codes should be unlinked. [6]
51
/
02
•
characterised by the carrier [6]
51
/
04
•
•
Organic compounds [6]
51
/
06
•
•
•
Macromolecular compounds [6]
51
/
08
•
•
•
Peptides, e.g. proteins [6]
51
/
10
•
•
•
•
Antibodies or immunoglobulins; Fragments thereof [6]
51
/
12
•
characterised by a special physical form, e.g. emulsion, microcapsules, liposomes [6]
Indexing scheme associated with group A 61 K 51/00, relating to the nature or the activity of the radioactive substance. The indexing codes should be unlinked. [6]
Note
Attention is drawn to Chapter IV of the Guide which sets forth the rules concerning the application and presentation of the different types of indexing code. [6]
